Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -5.21% | 161.91 | 0.0% | $1387.78m | |
| NVAX | Novavax, Inc. | -2.57% | 221.50 | 80.0% | $650.79m | |
| AMGN | Amgen, Inc. | 0.10% | 255.97 | 1.3% | $554.37m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -5.63% | 7.55 | 0.7% | $527.77m | |
| ILMN | Illumina, Inc. | 1.30% | 404.18 | 3.5% | $527.33m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.58% | 499.69 | 2.7% | $447.00m | |
| GILD | Gilead Sciences, Inc. | -1.38% | 65.95 | 1.0% | $437.06m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.10% | 219.18 | 1.9% | $383.57m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.09% | 165.47 | 2.0% | $360.29m | |
| BNTX | BioNTech SE | -1.36% | 149.48 | 0.0% | $336.51m | |
| BIIB | Biogen, Inc. | -0.47% | 269.05 | 1.7% | $246.78m | |
| NBIX | Neurocrine Biosciences, Inc. | -1.79% | 94.85 | 4.9% | $180.78m | |
| EXAS | EXACT Sciences Corp. | -1.93% | 127.53 | 18.4% | $168.47m | |
| CRSP | CRISPR Therapeutics AG | -2.97% | 115.04 | 0.6% | $158.56m | |
| SGEN | Seagen Inc. | -1.02% | 144.01 | 5.8% | $140.14m |
Company Profile
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.